发明名称 |
Therapy for neurodegenerative diseases |
摘要 |
The present invention relates to a method for reducing symptoms related to a neurodegenerative disease and/or treating a neurodegenerative disease, this therapy comprising the administration of a therapeutically effective amount of at least two compounds selected from the group of an inhibitor of microglial activation, an antiglutominergic agent and a voltage gated calcium channer blocker to a patient suffering from a neurodegenerative disease. The present invention also relates to a composition for reducing symptoms related to a neurodegenerative disease and/or treating a neurodegenerative disease, comprising a therapeutically effective amount of at least two compounds selected from the group of an inhibitor of microglial activation, an antiglutaminergic agent and a voltage gated calcium channel blocker in association with a pharmaceutically acceptable carrier.
|
申请公布号 |
US2003083318(A1) |
申请公布日期 |
2003.05.01 |
申请号 |
US20020279725 |
申请日期 |
2002.10.25 |
申请人 |
JULIEN JEAN-PIERRE;KRIZ JASNA |
发明人 |
JULIEN JEAN-PIERRE;KRIZ JASNA |
分类号 |
A61K31/426;A61K31/44;A61K31/65;A61K45/06;A61K49/00;(IPC1-7):A61K31/65 |
主分类号 |
A61K31/426 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|